Drug Database
Back to search

Poland· PL-100376660

Lizymax

A ibuprofen product containing ibuprofenum lysinum, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 12 of our 19 countries.

ATC M01AE01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLizymaxATCM01AE01REGISTER NO.PL-100376660PACKS LISTED5CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ibuprofenum lysinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ibuprofen is registered in 12 of 19 countries.

Countries holding a registration under ATC M01AE01 (ibuprofen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search ibuprofen products by name

Ibuprofen · ATC M01AE01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ibuprofen costs, country by country.

Normalised to the WHO defined daily dose (1.2 g), the median price runs from $0.28 in Italy to $1.24 in Switzerland — a ×4.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ibuprofen · price per daily dose (1.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.24
  • IT Italy$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Ibuprofenum lysinum
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
M01AE01
ATC class
Ibuprofen
Defined daily dose
1.2 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

  • gtin
    05909991303860
  • gtin
    05909991303884
  • gtin
    05909991303853
  • gtin
    05909991303877
  • gtin
    05909991303891

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

886 interactions on record for ibuprofen.

Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ibuprofen against other medicinesHow interaction checks work

Ibuprofen · interactions on record

886 records

  • 71 severe
  • 306 moderate
  • 15 minor
  • 413 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe

81 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under M01AE01

Ibuprofen, as other registers publish it.

All ibuprofen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ac9007a4-4304-47b1-9a2c-cc557339c22f
GET /v1/drugs/ac9007a4-4304-47b1-9a2c-cc557339c22f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "684 mg",
  "packaging": "05909991303860 ¦ OTC ¦ 117587\n15 tabl.\n05909991303884 ¦ OTC ¦ 117588\n30 tabl.\n05909991303853 ¦ OTC ¦ 118848\n10 tabl.\n05909991303877 ¦ OTC ¦ 118849\n20 tabl.\n05909991303891 ¦ OTC ¦ 118850\n50 tabl.",
  "substance": "Ibuprofenum 400 mg",
  "common_name": "Ibuprofenum lysinum",
  "pl_product_id": "100376660",
  "pozwolenie_nr": "23557",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about ibuprofen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console